Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $2.2 million.

  • Surgery Partners' Other Working Capital Changes fell 7582.42% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.9 million, marking a year-over-year decrease of 1937.57%. This contributed to the annual value of $46.8 million for FY2024, which is 20993.38% up from last year.
  • According to the latest figures from Q3 2025, Surgery Partners' Other Working Capital Changes is $2.2 million, which was down 7582.42% from $20.4 million recorded in Q2 2025.
  • In the past 5 years, Surgery Partners' Other Working Capital Changes ranged from a high of $61.7 million in Q1 2025 and a low of -$34.9 million during Q3 2023
  • In the last 5 years, Surgery Partners' Other Working Capital Changes had a median value of $7.1 million in 2021 and averaged $13.5 million.
  • Per our database at Business Quant, Surgery Partners' Other Working Capital Changes crashed by 35000.0% in 2022 and then skyrocketed by 175769.23% in 2024.
  • Surgery Partners' Other Working Capital Changes (Quarter) stood at $41.3 million in 2021, then rose by 11.62% to $46.1 million in 2022, then dropped by 20.39% to $36.7 million in 2023, then crashed by 125.61% to -$9.4 million in 2024, then surged by 123.4% to $2.2 million in 2025.
  • Its Other Working Capital Changes stands at $2.2 million for Q3 2025, versus $20.4 million for Q2 2025 and $61.7 million for Q1 2025.